Predictions
Biogen Inc.
Start price
Target price
Perf. (%)
€208.25
27.12.21
27.12.21
€215.00
27.12.22
27.12.22
23.82%
28.12.22
28.12.22
Could be worthwhile Investment >10% per year
Johnson & Johnson
Start price
Target price
Perf. (%)
€140.70
27.11.21
27.11.21
€160.00
27.11.22
27.11.22
21.35%
28.11.22
28.11.22
Could be worthwhile Investment >10% per year
Significant cyclical dependencies
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€533.60
09.11.21
09.11.21
€600.00
09.11.22
09.11.22
38.91%
10.11.22
10.11.22
Could be worthwhile Investment >10% per year
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€338.70
07.10.22
07.10.22
€350.00
07.10.23
07.10.23
7.12%
29.10.22
29.10.22
Higher EBIT margin than peer group
Differentiated customer and product portfolio
Medium risks for its business
Top 10 in its market
Gilead Sciences Inc
Start price
Target price
Perf. (%)
€59.87
15.05.22
15.05.22
€68.00
15.05.23
15.05.23
32.12%
28.10.22
28.10.22
Could be worthwhile Investment >10% per year
positive Cash Flow expected
ROE higher than 15% per year
Normal challenges to pay loans and raise capital
Vertex Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€158.36
17.06.21
17.06.21
€165.00
17.06.22
17.06.22
59.60%
18.06.22
18.06.22
Could be worthwhile Investment >10% per year
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€463.95
25.01.21
25.01.21
€500.00
25.01.22
25.01.22
15.42%
26.01.22
26.01.22
Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
Johnson & Johnson
Start price
Target price
Perf. (%)
€132.40
14.01.21
14.01.21
€144.00
14.01.22
14.01.22
10.89%
15.01.22
15.01.22
Johnson & Johnson
Start price
Target price
Perf. (%)
€125.32
28.12.20
28.12.20
€140.00
28.12.21
28.12.21
20.17%
29.12.21
29.12.21
Biogen Inc.
Start price
Target price
Perf. (%)
€243.10
18.10.21
18.10.21
€210.00
02.01.23
02.01.23
-12.53%
16.12.21
16.12.21
Could be worthwhile Investment >10% per year
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€442.80
23.11.20
23.11.20
€555.00
23.11.21
23.11.21
29.97%
24.11.21
24.11.21
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Standard Investments for future growth
Regeneron Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€529.00
22.11.20
22.11.20
€500.00
22.11.21
22.11.21
7.75%
23.11.21
23.11.21
Abbott Laboratories
Start price
Target price
Perf. (%)
€85.41
21.08.20
21.08.20
€110.00
04.11.21
04.11.21
31.07%
05.11.21
05.11.21
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€131.66
06.06.20
06.06.20
€205.00
04.11.21
04.11.21
77.81%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Eli Lilly Corp.
Start price
Target price
Perf. (%)
€141.50
16.04.20
16.04.20
€175.00
04.11.21
04.11.21
65.44%
05.11.21
05.11.21
Pfizer Inc.
Start price
Target price
Perf. (%)
€27.04
17.03.20
17.03.20
€33.21
04.11.21
04.11.21
47.75%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year
Alexion Pharmaceutical Inc.
Start price
Target price
Perf. (%)
€70.50
12.03.20
12.03.20
€145.00
04.11.21
04.11.21
119.55%
05.11.21
05.11.21
Could be worthwhile Investment >10% per year